Apple may be moving towards commoditizing the on-the-wrist ECG, but other companies in the space aren’t resting on their laurels. AliveCor, which has offered an smartphone-connected ECG since 2012 and ...
Mobile consumer ECG maker AliveCor announced today that its long-teased six-lead ECG device has been cleared by the FDA and will be available to customers in June of this year. “[The KardiaMobile 6L ...
US-based AliveCor has received US Food and Drug Administration (FDA) approval for the next generation of its KAI 12L artificial intelligence (AI), powering the Kardia 12L ECG System. This update ...
KardiaMobile 6L Max is powered by advanced AI to offer a wider range of arrhythmia detection, more insights, and ongoing access to board-certified cardiologist ECG reviews. KardiaAlert is a ...
Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart ...
MOUNTAIN VIEW, Calif., Jan. 13, 2026 (GLOBE NEWSWIRE) -- AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ...
When AliveCor launched in 2011, it had a simple mission: Empower people to take control of their heart health. It did that by disrupting the field of cardiology and designing a Food and Drug ...
The accuracy of a several popular consumer smart devices for detecting atrial fibrillation (AF) did not improve over a roughly 2-year period despite frequent software updates, the single-center Basel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results